Caas Capital Management LP Foghorn Therapeutics Inc. Transaction History
Caas Capital Management LP
- $1.31 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding FHTX
# of Institutions
70Shares Held
23.6MCall Options Held
7.7KPut Options Held
1.4K-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$67.2 Million5.6% of portfolio
-
Raymond James & Associates St Petersburg, FL2.23MShares$11.8 Million0.01% of portfolio
-
Euclidean Capital LLC New York, NY1.57MShares$8.34 Million1.36% of portfolio
-
Black Rock Inc. New York, NY1.32MShares$6.97 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$5.84 Million0.0% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $221M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...